BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 11490422)

  • 1. [The role of heparin in prevention of deep veins thrombosis and pulmonary artery thromboembolism in therapeutic regime patients].
    Panchenko EP
    Klin Med (Mosk); 2001; 79(3):59-62. PubMed ID: 11490422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of obesity on outcomes after fondaparinux, enoxaparin, or heparin treatment for acute venous thromboembolism in the Matisse trials.
    Davidson BL; Büller HR; Decousus H; Gallus A; Gent M; Piovella F; Prins MH; Raskob GE; Segers AE; Lensing AW;
    J Thromb Haemost; 2007 Jun; 5(6):1191-4. PubMed ID: 17403087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized comparison of enoxaparin with unfractionated heparin for the prevention of venous thromboembolism in medical patients with heart failure or severe respiratory disease.
    Kleber FX; Witt C; Vogel G; Koppenhagen K; Schomaker U; Flosbach CW;
    Am Heart J; 2003 Apr; 145(4):614-21. PubMed ID: 12679756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trials.
    van Doormaal FF; Raskob GE; Davidson BL; Decousus H; Gallus A; Lensing AW; Piovella F; Prins MH; Büller HR
    Thromb Haemost; 2009 Apr; 101(4):762-9. PubMed ID: 19350123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prevention of venous thrombosis: role of heparins].
    Wahl D; Lepaux DJ; Piquemal R; Frédéric M; Cayrol C; Lecompte T; Thibaut G
    Therapie; 1998; 53(6):575-8. PubMed ID: 10070236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Venous thromboembolic risk and prevention in acute medical illness.
    Hampton KK
    Int J Clin Pract; 2003 Jun; 57(5):424-7. PubMed ID: 12846349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of venous thromboembolism in the acute treatment phase after spinal cord injury: a randomized, multicenter trial comparing low-dose heparin plus intermittent pneumatic compression with enoxaparin.
    Spinal Cord Injury Thromboprophylaxis Investigators
    J Trauma; 2003 Jun; 54(6):1116-24; discussion 1125-6. PubMed ID: 12813332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prophylaxis of venous thromboembolic complications in patients operated on abdominal organs].
    Baeshko AA; Shorokh GP; Krukovich EA; Klimovich VV; Iushkevich VA
    Khirurgiia (Mosk); 2001; (2):12-7. PubMed ID: 11247015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Venous thromboembolism prophylaxis conversion in nonsurgical inpatients.
    Carroll DN; Hudson EB
    Ann Pharmacother; 2003 Sep; 37(9):1194-6. PubMed ID: 12921498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of major venous thromboembolism following total hip or knee replacement: a randomized comparison of low-molecular-weight heparin with unfractionated heparin (ECHOS Trial).
    Haas S; Breyer HG; Bacher HP; Fareed J; Misselwitz F; Victor N; Weber J;
    Int Angiol; 2006 Dec; 25(4):335-42. PubMed ID: 17164738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deep vein thrombosis and anticoagulant therapy.
    Sullano MA; Ortiz EJ
    Nurs Clin North Am; 2001 Dec; 36(4):645-63, v. PubMed ID: 11726345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Traumatic brain injury is associated with the development of deep vein thrombosis independent of pharmacological prophylaxis.
    Reiff DA; Haricharan RN; Bullington NM; Griffin RL; McGwin G; Rue LW
    J Trauma; 2009 May; 66(5):1436-40. PubMed ID: 19430251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Warfarin or enoxaparin: the choice for the patient with venous thrombosis in the first month of treatment].
    Vorob'eva NM; Panchenko EP; Kirienko AI; Dobrovol'skiĭ AB; Titaeva EV; Ermolina OV; Balakhonova TV; Andriiashkin VV; Leont'ev SG
    Ter Arkh; 2009; 81(9):57-61. PubMed ID: 19827655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized evaluation of betrixaban, an oral factor Xa inhibitor, for prevention of thromboembolic events after total knee replacement (EXPERT).
    Turpie AG; Bauer KA; Davidson BL; Fisher WD; Gent M; Huo MH; Sinha U; Gretler DD;
    Thromb Haemost; 2009 Jan; 101(1):68-76. PubMed ID: 19132191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A retrospective study on the use of a low-molecular-weight heparin for thromboembolism prophylaxis in large-volume liposuction and body contouring procedures.
    Newall G; Ruiz-Razura A; Mentz HA; Patronella CK; Ibarra FR; Zarak A
    Aesthetic Plast Surg; 2006; 30(1):86-95; discussion 96-7. PubMed ID: 16404651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enoxaparin for the prevention of venous thromboembolism.
    Calderon EJ; Varela JM; Gonzalez de la Puente MA
    N Engl J Med; 2000 Jan; 342(2):136-7. PubMed ID: 10636758
    [No Abstract]   [Full Text] [Related]  

  • 17. Enoxaparin for the prevention of VT in acutely ill patients.
    Tseng CW; Huntington J
    J Fam Pract; 1999 Dec; 48(12):940-1. PubMed ID: 10628571
    [No Abstract]   [Full Text] [Related]  

  • 18. Postoperative deep vein thrombosis prophylaxis: a retrospective analysis in 1000 consecutive hip fracture patients treated in a community hospital setting.
    Ennis RS
    J South Orthop Assoc; 2003; 12(1):10-7. PubMed ID: 12735619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevention of venous thromboembolism in internal medicine and neurology].
    Malý J; Dulícek P; Penka M; Malý R; Gumulec J
    Vnitr Lek; 2006 Mar; 52 Suppl 1():63-7. PubMed ID: 16637452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BAY 59-7939: an oral, direct factor Xa inhibitor for the prevention of venous thromboembolism in patients after total knee replacement. A phase II dose-ranging study.
    Turpie AG; Fisher WD; Bauer KA; Kwong LM; Irwin MW; Kälebo P; Misselwitz F; Gent M;
    J Thromb Haemost; 2005 Nov; 3(11):2479-86. PubMed ID: 16241946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.